Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in an oncology department;Evaluation de la survie et des facteurs pronostiques de 2000 cancers broncho-pulmonaires enregistres en 10 ans dans une unite multidisciplinaire de cancerologie

Bulletin du Cancer

Volumn 84, Issue 2, 1997, Pages 155-161

  Moro, Denis ^a   Nagy Mignotte, Hélène ^a   Bolla, Michel ^a   Colonna, Marc ^b   Brichon, Pierre Yves ^a   Brambilla, Christian ^a   Schaerer, René ^a   Vrousos, Constantin ^a  

^a HÔPITAL MICHALLON   (France)

^b Registre du Cancer de l'Isere   (France)

Author keywords

long term survivors; lung cancer; non small cell lung cancer; prognostic factors; small cell lung cancer

Indexed keywords

ADULT; AGE; AGED; ARTICLE; FEMALE; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SEX; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BRONCHOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; FRANCE; HUMANS; INTERPROFESSIONAL RELATIONS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONCOLOGY SERVICE, HOSPITAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030941240     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Albain KS, Crowley JJ, Leblanc M, Livingston RB. Determinants of improved outcome in small cell lung cancer : an analysis of the 2 580 patients southwest oncology group database. J Clin Oncol 1990; 8: 1563-74.
2. Albain KS, Crowley JJ, Leblanc M, Livingston RB. Survival determinants in extensive stage non-small cell lung cancer : the Southwest Oncology Group Experience. J Clin Oncol 1991a; 9: 1618-26.
3. Albain KS, Crowley JJ, Livingston RB. Long term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group Experience. Chest 1991b; 99:1425-32.
4. Bolla M. Les aspects institutionnels de la concertation en cancérologie au sein d'un centre hospitalier-universitaire. Bull Cancer 1991; 78: 31-5.
5. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst 1993; 85: 979-87.
6. Choi NC, Carey RW, Kaufman SD, Grillo HC, Younger J, Wilkins EW. Small cell carcinoma of the lung. A progress report of 15 years experience. Cancer 1987; 59: 6-14.
7. Chute JP, Venzon DJ, Hankins L, Ihde DC, Johnson BE. Twenty years of clinical research on patients with small cell lung cancer shows modest prolongation of survival inrecently treated limited stage patients. Proc Am Soc Clin Oncol 1995; 14: 354.
8. Davis S, Wright PW, Schulman SF, Scholes D, Thorning D, Hammar S. Long term survival in small cell carcinoma of the lung : a population experience. J Clin Oncol 1985; 3: 80-91.
9. Depierre A, Milleron B, Lebeau B, Moro D, Chastang C, et al. An ongoing randomized study of neoadjuvant chemotherapy in resectable non small cell lung cancer. Semin Oncol 1994; 21: 16-9.
10. Douglas IS, White SR. Therapeutic empiricism. The case against chemotherapy in non-small cell lung cancer. Am J Respir Crit Care Med 1995; 151: 1288-91.
11. Grilli R, Oxman AD, Julian JM. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough? J Clin Oncol 1993; 11: 1866-72.
12. Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol 1992; 10: 1519-24.
13. Ihde DC, Tucker MA. Second primary malignancies in small-cell lung cancer. A major consequence of modest success. J Clin Oncol 1992; 10: 1511-3.
14. Lassen U, Osterlind K, Hansen M, Dombernowski P, Bergman B, Hansen H. Long term survival in small cell lung cancer : post-treatment characteristics in patients surviving 5 to 18 years. An analysis of 1714 consecutive patients. J Clin Oncol 1995; 13: 1215-20.
15. Lebeau B, Chastang C, Schuller MP, Thiberville L, et al. Chimiothérapie des cancers bronchiques à petites cellules: importance pronostique d'une réponse complète (1 280 patients). Presse Med 1995; 24: 217-21.
16. Marino P, Pampallona S, Preatoni A, Cantoni A, Invernizzi F. Chemotherapy versus supportive care in advanced non-small cell lung cancer : results of a metaanalysis of the litterature. Chest 1994; 106: 861-5.
17. Masters GA, Vokes EE. Chemotherapy is for non-small cell lung cancer. Am J Respir Crit Care Med 1995; 151: 1285-7.
18. Menegoz F, Colonna M, Exbrayat C. Le cancer dans l'Isère 1979-1990. Registre du cancer de l'Isère, ed. Grenoble, 1995.
19. Moro D, Jacoulet P, Depierre A, Guerin JC, et al. Small cell lung cancer in patients surviving longer than thirty months : a multi center study. Annals of Oncology 1992; 3 (suppl. 5): 37.
20. Moro D, Jacoulet P, Quoix E, Ranfaing E, et al. Small cell lung cancer : patients surviving longer than thirty months. Anticancer Res 1994; 14: 301-4.
21. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89: 225-33.
22. Mountain CF. Lung cancer staging classification. Clin Chest Med 1993; 14: 45-53.
23. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer : a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 1995; 311: 899-909.
24. Osterlind K, Hansen HH, Hansen M, Dombernovsky P, Andersen PK. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol 1986; 4: 1307-13.
25. Paesman M, Sculier JP, Libert P, Bureau G, Dabouis G, et al. Prognostic factors for survival in advanced non-small cell lung cancer : univariate and multivariate analyses including recursive partitioning and amalgation algorythms in 1 052 patients. J Clin Oncol 1995; 13: 1221-30.
26. Pater JL, Loeb M. Non anatomic prognostic factors in carcinoma of the lung : a multivariate analysis. Cancer 1982; 50: 326-31.
27. Read RC, Schaefer R, North N, Walls R. Diameter, cell type, and survival in stage I primary non-small-cell lung cancer. Arch Surg 1988; 123: 446-9.
28. Rosell R, Gomez-Codina J, Camps C. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 326: 524-30.
29. Rosti G, Crino L, Tondini M, Scagliotti G, Favaretto M, Clerici M, Barni S, Marangolo M. Secondary malignant tumor affecting small cell lung cancer long survivors. Results of the italian survey. Annals of Oncology 1992; 3 (suppl. 5): 66.
30. Roth J, Fossela F, Komaki R. A randomized trial comparing perioperative chemotherapy plus surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994; 86: 673-80.
31. Sellman M, Henze A, Peterffy A. Extended intrathoracic resection for lung cancer. Scand J Thorac Cardiovasc Surg 1987; 21: 69-72.
32. Souhami RL, Law K. Longevity in small cell lung cancer. Br J Cancer 1990; 61: 584-9.
33. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, et al. Polychemotherapy in advanced non-small cell lung cancer : a metaanalysis. Lancet 1993; 342: 19-21.
34. Spiegelman D, Maurer LH, Ware JH, Perry MC, Chahinian AP, Comis R, Eaton W, Zimmer B, Green M. Prognostic factors in small cell carcinoma of the lung : an analysis of 1 521 patients. J Clin Oncol 1989; 7: 344-54.
35. Strauss GM, Kwiatkowski DJ, Harpole DH, Lynch TJ, Skarin AT, Sugarbaker DJ. Molecular and pathologic markers in stage I non-small cell lung cancer. J Clin Oncol 1995; 13: 1265-79.
36. The Ludwig Cancer Study Group. Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg 1987; 205: 67-71.
37. Vrousos C. L'unité de concertation et de recherche pour le traitement des affections cancéreuses du CHU de Grenoble. Bull cancer 1991; 78: 5-6.